Background/Objectives: Maxillary sinus floor augmentation (MSFA) is a predictable procedure for the rehabilitation of the atrophic posterior maxilla. The prolonged healing time associated with particulate bone grafts poses a clinical challenge. This review aimed to evaluate the clinical, radiographic, and histomorphometric efficacy of autologous platelet-rich fibrin (PRF) combined with bone grafts versus bone grafts alone in MSFA.
Methods: A search of databases was conducted until May 2026. We included randomized controlled trials, controlled clinical trials, and cohort studies. Random-effects meta-analyses were performed for new bone formation (NFB%), residual graft (RG%), implant stability quotient (ISQ), and vertical bone height gain. The certainty of the evidence was appraised using the GRADE framework.
Results: Thirty-two studies encompassing 728 augmented sinuses in 563 patients met the inclusion criteria. The adjunctive use of PRF significantly increased NFB% (MD = 4.10%; 95% CI: 1.59–6.61;
p = 0.005; 10 studies; 204 sinuses;
I2 = 20.9%; moderate certainty of evidence), with a 95% prediction interval that excluded the null. No statistically significant difference was demonstrated for RG% (MD = −2.71%; 95% CI: −6.08–0.67;
p = 0.103; 10 studies; 204 sinuses;
I2 = 45.2%; very low certainty of evidence), the latter estimate being sensitive to the omission of individual studies. Exploratory subgroup analyses are reported as hypothesis-generating only; the significant between-subgroup contrasts for residual graft were generated by strata containing a single study each. There were no statistically significant differences in ISQ (MD = 1.74; 95% CI: −4.38–7.86;
p = 0.432; 4 studies; 140 implants;
I2 = 92.1%) or vertical bone height gain (MD = −0.35 mm; 95% CI: −2.82–2.13;
p = 0.687); both outcomes exhibited substantial heterogeneity and very low certainty of evidence, and their CIs remain compatible with a clinically relevant benefit.
Conclusions: The incorporation of PRF into particulate bone grafts during MSFA enhances histological graft maturation by increasing NFB, without a demonstrable effect on RG. This histomorphometric benefit did not translate to improvements in radiographic bone height, bone density, or early implant stability, although the evidence for these outcomes remains imprecise. Therefore, PRF may be regarded as a low-cost autologous adjunct where accelerated histological graft maturation is the specific objective, but the present evidence does not justify a general recommendation for its routine use.
Full article